Laboratório de Neuroquímica e Psicofarmacologia, Programa de Pós-Graduação em Biologia Celular e Molecular, Escola de Ciências da Saúde e da Vida, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil.
Laboratório de Neuroquímica e Psicofarmacologia, Programa de Pós-Graduação em Biologia Celular e Molecular, Escola de Ciências da Saúde e da Vida, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil; Programa de Pós-Graduação em Medicina e Ciências da Saúde, Escola de Medicina, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil.
Prog Neuropsychopharmacol Biol Psychiatry. 2023 Jul 13;125:110753. doi: 10.1016/j.pnpbp.2023.110753. Epub 2023 Mar 17.
The dopaminergic neurotransmitter system is implicated in several brain functions and behavioral processes. Alterations in it are associated with the pathogenesis of several human neurological disorders. Pharmacological agents that interact with the dopaminergic system allow the investigation of dopamine-mediated cellular and molecular responses and may elucidate the biological bases of such disorders. Zebrafish, a translationally relevant biomedical research organism, has been successfully employed in prior psychopharmacology studies. Here, we evaluated the effects of quinpirole (dopamine D2/D3 receptor agonist) in adult zebrafish on behavioral parameters, brain-derived neurotrophic factor (BDNF) and neurotransmitter levels. Zebrafish received intraperitoneal injections of 0.5, 1.0, or 2.0 mg/kg quinpirole or saline (control group) twice with an inter-injection interval of 48 h. All tests were performed 24 h after the second injection. After this acute quinpirole administration, zebrafish exhibited decreased locomotor activity, increased anxiety-like behaviors and memory impairment. However, quinpirole did not affect social and aggressive behavior. Quinpirole-treated fish exhibited stereotypic swimming, characterized by repetitive behavior followed by immobile episodes. Moreover, quinpirole treatment also decreased the number of BDNF-immunoreactive cells in the zebrafish brain. Analysis of neurotransmitter levels demonstrated a significant increase in glutamate and a decrease in serotonin, while no alterations were observed in dopamine. These findings demonstrate that dopaminergic signaling altered by quinpirole administration results in significant behavioral and neuroplastic changes in the central nervous system of zebrafish. Thus, we conclude that the use of quinpirole administration in adult zebrafish may be an appropriate tool for the analysis of mechanisms underlying neurological disorders related to the dopaminergic system.
多巴胺能神经递质系统参与多种脑功能和行为过程。其改变与几种人类神经疾病的发病机制有关。与多巴胺能系统相互作用的药物制剂允许研究多巴胺介导的细胞和分子反应,并可能阐明此类疾病的生物学基础。斑马鱼是一种具有转化相关性的生物医学研究生物,已成功应用于先前的精神药理学研究。在这里,我们评估了腹腔内注射不同剂量(0.5、1.0 或 2.0mg/kg)的喹吡罗(多巴胺 D2/D3 受体激动剂)对成年斑马鱼的行为参数、脑源性神经营养因子(BDNF)和神经递质水平的影响。两次注射之间的间隔为 48 小时。所有测试均在第二次注射后 24 小时进行。在急性喹吡罗给药后,斑马鱼表现出运动活性降低、焦虑样行为增加和记忆障碍。然而,喹吡罗对社交和攻击行为没有影响。喹吡罗处理的鱼表现出刻板游泳,其特征是重复行为后出现静止期。此外,喹吡罗处理还减少了斑马鱼大脑中 BDNF 免疫反应细胞的数量。神经递质水平分析表明谷氨酸显著增加,而 5-羟色胺减少,多巴胺没有变化。这些发现表明,喹吡罗给药改变多巴胺能信号会导致斑马鱼中枢神经系统出现显著的行为和神经可塑性变化。因此,我们得出结论,在成年斑马鱼中给予喹吡罗可能是分析与多巴胺能系统相关的神经疾病机制的合适工具。